Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Gabapentin in HPV-Related Oropharyngeal Cancer
NCT03423264Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Jan 2018
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in oral mucositis (OM), sponsored by University of Chicago. Planned start Jan 2018; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03423264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03423264.